New insights into rosacea pathophysiology: a review of recent findings
- PMID: 24229632
- DOI: 10.1016/j.jaad.2013.04.045
New insights into rosacea pathophysiology: a review of recent findings
Abstract
Rosacea is a common, chronic inflammatory skin disease of poorly understood origin. Based on its clinical features (flushing, chronic inflammation, fibrosis) and trigger factors, a complex pathobiology involving different regulatory systems can be anticipated. Although a wealth of research has shed new light over recent years on its pathophysiology, the precise interplay of the various dysregulated systems (immune, vascular, nervous) is still poorly understood. Most authors agree on 4 major clinical subtypes of rosacea: erythematotelangiectatic rosacea, papulopustular rosacea, phymatous rosacea, and ocular rosacea. Still, it needs to be elucidated whether these subtypes develop in a consecutive serial fashion or if any subtypes may occur individually as part of a syndrome. Because rosacea often affects multiple family members, a genetic component is also suspected, but the genetic basis of rosacea remains unclear. During disease manifestation and early stage, the innate immune system and neurovascular dysregulation seem to be driving forces in rosacea pathophysiology. Dissection of major players for disease progression and in advanced stages is severely hampered by the complex activation of the innate and adaptive immune systems, enhanced neuroimmune communication, profound blood vessel and possibly lymphatic vessel changes, and activation of almost every resident cell in the skin. This review discusses some of the recent findings and aims to build unifying hypotheses for a modern understanding of rosacea pathophysiology.
Keywords: AMP; CAMP; CCL2; CXCL8; ER; ETR; H2R; HTR3A; Histamine receptor-3; IL; KLK; MMP; NF-κB-C/EBPa; NK; Nuclear factor-kappa-B-C/EBPa; PACAP; PPR; PhR; SP; Serotonin receptor-3A; TGF; TLR; TRP; TRPA1; TRPV; TRPV1; Th1; UV; VEGF-A; adaptive immunity; antimicrobial peptide; antimicrobial peptides; cathelicidin antimicrobial peptide; cysteine-X-cysteine chemokine-8; cysteine-cysteine chemokine-2; cytokines; endoplasmic reticulum; erythematotelangiectatic rosacea; fibrosis; innate immunity; interleukin; kallikrein; mast cells; matrix metalloproteinases; natural killer; neurovascular system; papulopustular rosacea; phymatous rosacea; pituitary adenylate cyclase activating polypeptide; substance P; toll-like receptor; transforming growth factor; transient receptor potential channel; transient receptor potential channel ankyrin receptor 1; transient receptor potential channel vanilloid receptor 1; transient receptor potential ion channel vanilloid type; type 1 helper T cell; ultraviolet; vascular endothelial growth factor-A.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Similar articles
-
[Current insights into the pathophysiology of rosacea].Hautarzt. 2013 Jul;64(7):481-8. doi: 10.1007/s00105-012-2516-7. Hautarzt. 2013. PMID: 23760500 Review. German.
-
Recent advances in understanding and managing rosacea.F1000Res. 2018 Dec 3;7:F1000 Faculty Rev-1885. doi: 10.12688/f1000research.16537.1. eCollection 2018. F1000Res. 2018. PMID: 30631431 Free PMC article. Review.
-
Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.Mol Vis. 2021 May 13;27:323-353. eCollection 2021. Mol Vis. 2021. PMID: 34035646 Free PMC article. Review.
-
Signaling pathways and targeted therapy for rosacea.Front Immunol. 2024 Sep 16;15:1367994. doi: 10.3389/fimmu.2024.1367994. eCollection 2024. Front Immunol. 2024. PMID: 39351216 Free PMC article. Review.
-
Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.Exp Dermatol. 2017 Aug;26(8):659-667. doi: 10.1111/exd.13143. Epub 2016 Oct 9. Exp Dermatol. 2017. PMID: 27376863 Review.
Cited by
-
Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways.J Invest Dermatol. 2015 Sep;135(9):2198-2208. doi: 10.1038/jid.2015.141. Epub 2015 Apr 7. J Invest Dermatol. 2015. PMID: 25848978
-
Evaluation of Dermatological and Neurological Aspects of the Relationship between Rosacea and Headaches.Diagnostics (Basel). 2023 Dec 22;14(1):23. doi: 10.3390/diagnostics14010023. Diagnostics (Basel). 2023. PMID: 38201332 Free PMC article.
-
Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline.Int J Ophthalmol. 2015 Jun 18;8(3):544-9. doi: 10.3980/j.issn.2222-3959.2015.03.19. eCollection 2015. Int J Ophthalmol. 2015. PMID: 26086005 Free PMC article.
-
Rosacea Topical Treatment and Care: From Traditional to New Drug Delivery Systems.Mol Pharm. 2023 Aug 7;20(8):3804-3828. doi: 10.1021/acs.molpharmaceut.3c00324. Epub 2023 Jul 21. Mol Pharm. 2023. PMID: 37478169 Free PMC article. Review.
-
Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.Int J Mol Sci. 2021 Jan 19;22(2):931. doi: 10.3390/ijms22020931. Int J Mol Sci. 2021. PMID: 33477764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical